This conference is concentrated on the commercialization of cell and gene therapies, with a focus on navigating challenges such as regulations, reimbursement, and large-scale production.

Learn more about this conference.

Visit Us in the Exhibit Area
This conference is a first time for us, and we will be in booth 203. We’d love to meet with you and discuss how we are helping our customers with consistent and robust processes for cell and gene therapy.

We have submitted some good work and once excepted our posters will be listed below:

Ensure Process Robustness with Real-Time Monitoring

To create effective cell therapies, manufacturers need tightly controlled and well-understood production processes. This is achieved by integrating Process Analytical Technology (PAT) with automated manufacturing systems. MAVEN and MAVERICK are prime examples. These systems seamlessly connect with existing setups, enabling continuous monitoring and control of vital process parameters like glucose, lactate, and total biomass. This not only deepens our understanding of the process but also ensures consistency and minimizes the need for manual intervention.

Additionally, REBEL allows for frequent monitoring of amino acid concentrations within the culture medium during cell expansion. This real-time data ensures that any variations in cell health or growth can’t be attributed to unnoticed changes in the media formulation.